Literature DB >> 1756141

Stunning: damaging or protective to the myocardium?

R Ferrari1, O Visioli.   

Abstract

There are several potential outcomes of myocardial ischemia. When ischemia is severe and prolonged, irreversible damage occurs and there is no recovery of contractile function. Interventions aimed at reducing mechanical activity and oxygen demand, either before ischemia or during reperfusion, have been shown to delay the onset of ischemic damage and to improve recovery on reperfusion. When myocardial ischemia is less severe but still prolonged, myocytes may remain viable but exhibit depressed contractile function. Under these conditions, reperfusion restores complete contractile performance. This type of ischemia, leading to a reversible, chronic left ventricular dysfunction, has been termed hibernating myocardium. Depression of mechanical activity is, actually, a protective mechanism whereby the hibernating cells reduce their oxygen demands in the setting of reduced oxygen supply. A third possible outcome after a short period of myocardial ischemia is a transient postischemic ventricular dysfunction, a situation termed stunned myocardium. As in the case of hibernating myocardium, the depressed contractile function occurring during stunning could be a protective mechanism, allowing the reperfused cells to gradually recover their metabolism and function.

Entities:  

Mesh:

Year:  1991        PMID: 1756141     DOI: 10.1007/bf00053556

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  57 in total

1.  The iron chelator desferrioxamine attenuates postischemic ventricular dysfunction.

Authors:  R Bolli; B S Patel; W X Zhu; P G O'Neill; C J Hartley; M L Charlat; R Roberts
Journal:  Am J Physiol       Date:  1987-12

2.  Influence of direct myocardial revascularization on left ventricular asynergy and function in patients with coronary heart disease. With and without previous myocardial infarction.

Authors:  K Chatterjee; H J Swan; W W Parmley; H Sustaita; H S Marcus; J Matloff
Journal:  Circulation       Date:  1973-02       Impact factor: 29.690

3.  Reversal of rest myocardial asynergy during exercise: a radionuclide scintigraphic study.

Authors:  A Kimchi; A Rozanski; C Fletcher; J Maddahi; H J Swan; D S Berman
Journal:  J Am Coll Cardiol       Date:  1985-11       Impact factor: 24.094

4.  Effect of D-600 on ischemic and reperfused rabbit myocardium: relation with timing and modality of administration.

Authors:  R Ferrari; G M Boffa; C Ceconi; S Curello; A Boraso; S Ghielmi; A Cargnoni
Journal:  Basic Res Cardiol       Date:  1989 Nov-Dec       Impact factor: 17.165

5.  Beta-adrenergic stimulation reverses postischemic myocardial dysfunction without producing subsequent functional deterioration.

Authors:  R Bolli; W X Zhu; M L Myers; C J Hartley; R Roberts
Journal:  Am J Cardiol       Date:  1985-12-01       Impact factor: 2.778

6.  Analysis of reported randomized trials of streptokinase therapy for acute myocardial infarction in the 1980s.

Authors:  B Patel; R A Kloner
Journal:  Am J Cardiol       Date:  1987-03-01       Impact factor: 2.778

7.  Effects of temperature on myocardial calcium homeostasis and mitochondrial function during ischemia and reperfusion.

Authors:  R Ferrari; R Raddino; F Di Lisa; C Ceconi; S Curello; A Albertini; W Nayler
Journal:  J Thorac Cardiovasc Surg       Date:  1990-05       Impact factor: 5.209

8.  Increased uptake of 18F-fluorodeoxyglucose in postischemic myocardium of patients with exercise-induced angina.

Authors:  P Camici; L I Araujo; T Spinks; A A Lammertsma; J C Kaski; M J Shea; A P Selwyn; T Jones; A Maseri
Journal:  Circulation       Date:  1986-07       Impact factor: 29.690

Review 9.  Superoxide dismutase: possible therapeutic use in cardiovascular disease.

Authors:  R Ferrari; C Ceconi; S Curello; S Ghielmi; A Albertini
Journal:  Pharmacol Res       Date:  1989 Nov-Dec       Impact factor: 7.658

10.  Myocardial recovery during post-ischaemic reperfusion: effects of nifedipine, calcium and magnesium.

Authors:  R Ferrari; A Albertini; S Curello; C Ceconi; F Di Lisa; R Raddino; O Visioli
Journal:  J Mol Cell Cardiol       Date:  1986-05       Impact factor: 5.000

View more
  4 in total

Review 1.  Hibernating myocardium in patients with coronary artery disease: identification and clinical importance.

Authors:  R Ferrari; G La Canna; R Giubbini; O Alfieri; O Visioli
Journal:  Cardiovasc Drugs Ther       Date:  1992-06       Impact factor: 3.727

2.  Effect of adenosine deaminase inhibition with pentostatin on myocardial stunning in dogs.

Authors:  T B McClanahan; D P Ignasiak; B J Martin; T E Mertz; K P Gallagher
Journal:  Basic Res Cardiol       Date:  1995 Mar-Apr       Impact factor: 17.165

Review 3.  Left ventricular dysfunction due to stunning and hibernation in patients.

Authors:  R Ferrari; G La Canna; R Giubbini; E Milan; C Ceconi; F de Giuli; P Berra; O Alfieri; O Visioli
Journal:  Cardiovasc Drugs Ther       Date:  1994-05       Impact factor: 3.727

Review 4.  Hibernating myocardium: its pathophysiology and clinical role.

Authors:  R Ferrari; F Ferrari; M Benigno; P Pepi; O Visioli
Journal:  Mol Cell Biochem       Date:  1998-09       Impact factor: 3.396

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.